106 related articles for article (PubMed ID: 22072104)
21. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
22. Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury.
Ma J; Weisberg A; Griffin JP; Vaughan DE; Fogo AB; Brown NJ
Kidney Int; 2006 Mar; 69(6):1064-72. PubMed ID: 16528256
[TBL] [Abstract][Full Text] [Related]
23. Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice.
Tomiyama-Hanayama M; Rakugi H; Kohara M; Mima T; Adachi Y; Ohishi M; Katsuya T; Hoshida Y; Aozasa K; Ogihara T; Nishimoto N
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F679-84. PubMed ID: 19570877
[TBL] [Abstract][Full Text] [Related]
24. BMPs and BMPRs in chicken ovary and effects of BMP-4 and -7 on granulosa cell proliferation and progesterone production in vitro.
Onagbesan OM; Bruggeman V; Van As P; Tona K; Williams J; Decuypere E
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E973-83. PubMed ID: 12888485
[TBL] [Abstract][Full Text] [Related]
25. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
26. Rosuvastatin preserves renal structure following unilateral ureteric obstruction in the neonatal rat.
Mazzei LJ; García IM; Altamirano L; Docherty NG; Manucha W
Am J Nephrol; 2012; 35(2):103-13. PubMed ID: 22212364
[TBL] [Abstract][Full Text] [Related]
27. Aldosterone upregulates vascular endothelial growth factor expression in mouse cortical collecting duct epithelial cells through classic mineralocorticoid receptor.
Lai L; Pen A; Hu Y; Ma J; Chen J; Hao CM; Gu Y; Lin S
Life Sci; 2007 Jul; 81(7):570-6. PubMed ID: 17655877
[TBL] [Abstract][Full Text] [Related]
28. Propofol increases bone morphogenetic protein-7 and decreases oxidative stress in sepsis-induced acute kidney injury.
Hsing CH; Chou W; Wang JJ; Chen HW; Yeh CH
Nephrol Dial Transplant; 2011 Apr; 26(4):1162-72. PubMed ID: 20864551
[TBL] [Abstract][Full Text] [Related]
29. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta1 mRNA ameliorates renal injury in hypertensive rats.
Tahira Y; Fukuda N; Endo M; Ueno T; Matsuda H; Saito S; Matsumoto K; Mugishima H
J Hypertens; 2007 Mar; 25(3):671-8. PubMed ID: 17278984
[TBL] [Abstract][Full Text] [Related]
30. RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice.
Taguchi K; Yamagishi SI; Yokoro M; Ito S; Kodama G; Kaida Y; Nakayama Y; Ando R; Yamada-Obara N; Asanuma K; Matsui T; Higashimoto Y; Brooks CR; Ueda S; Okuda S; Fukami K
Sci Rep; 2018 Feb; 8(1):2686. PubMed ID: 29422652
[TBL] [Abstract][Full Text] [Related]
31. Aldosterone and the kidney.
Fourkiotis VG; Hanslik G; Hanusch F; Lepenies J; Quinkler M
Horm Metab Res; 2012 Mar; 44(3):194-201. PubMed ID: 22161301
[TBL] [Abstract][Full Text] [Related]
32. Iron restriction inhibits renal injury in aldosterone/salt-induced hypertensive mice.
Sawada H; Naito Y; Oboshi M; Iwasaku T; Okuhara Y; Morisawa D; Eguchi A; Hirotani S; Masuyama T
Hypertens Res; 2015 May; 38(5):317-22. PubMed ID: 25693852
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease.
Brem AS; Gong R
Clin Sci (Lond); 2015 May; 128(9):527-35. PubMed ID: 25671776
[TBL] [Abstract][Full Text] [Related]
34. Aldosterone effects on glomerular structure and function.
Bernardi S; Toffoli B; Zennaro C; Bossi F; Losurdo P; Michelli A; Carretta R; Mulatero P; Fallo F; Veglio F; Fabris B
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):730-8. PubMed ID: 26283678
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of Mineralocorticoid Receptor Contributes to Development of Salt-Sensitive Hypertension after Ischemia-Reperfusion Injury in Rats.
Matsumoto T; Doi S; Nakashima A; Ike T; Sasaki K; Masaki T
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887178
[TBL] [Abstract][Full Text] [Related]
36. mPGES-1 deletion impairs aldosterone escape and enhances sodium appetite.
Jia Z; Aoyagi T; Kohan DE; Yang T
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F155-66. PubMed ID: 20335314
[TBL] [Abstract][Full Text] [Related]
37. Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury.
Ichikawa D; Kamijo-Ikemori A; Sugaya T; Shibagaki Y; Yasuda T; Hoshino S; Katayama K; Igarashi-Migitaka J; Hirata K; Kimura K
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F114-21. PubMed ID: 25339700
[TBL] [Abstract][Full Text] [Related]
38. Aldosterone Rapidly Enhances Levels of the Striatin and Caveolin-1 Proteins in Rat Kidney: The Role of the Mineralocorticoid Receptor.
Inthachart K; Manotham K; Eiam-Ong S; Eiam-Ong S
Endocrinol Metab (Seoul); 2019 Sep; 34(3):291-301. PubMed ID: 31565882
[TBL] [Abstract][Full Text] [Related]
39. Age-related changes in thirst, salt appetite, and arterial blood pressure in response to aldosterone-dexamethasone combination in rats.
Thunhorst RL; Xue B; Beltz TG; Johnson AK
Am J Physiol Regul Integr Comp Physiol; 2015 May; 308(10):R807-15. PubMed ID: 25833938
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium.
Sontia B; Montezano AC; Paravicini T; Tabet F; Touyz RM
Hypertension; 2008 Apr; 51(4):915-21. PubMed ID: 18268139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
